The global market for Microneedle Patch Transdermal Drug Delivery Systems was valued at US$ 3012 million in the year 2024 and is projected to reach a revised size of US$ 4246 million by 2031, growing at a CAGR of 5.1% during the forecast period.
The microneedle patch transdermal drug delivery system is applied to the patient"s skin by attaching the microneedle to the drug delivery patch and effectively administering the drug for a certain period of time. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microneedle Patch Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Patch Transdermal Drug Delivery Systems.
The Microneedle Patch Transdermal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microneedle Patch Transdermal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedle Patch Transdermal Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
3M
Becton
Endoderma
BD
Zosano Pharma
Raphas
Nanopass Tech
Corium International
Valeritas
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
SNvia
Small Lab
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microneedle Patch Transdermal Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microneedle Patch Transdermal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Overview
1.1 Product Definition
1.2 Microneedle Patch Transdermal Drug Delivery Systems by Type
1.2.1 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolving Microneedles
1.3 Microneedle Patch Transdermal Drug Delivery Systems by Application
1.3.1 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Microneedle Patch Transdermal Drug Delivery Systems Sales 2020-2031
1.4.3 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Competition by Manufacturers
2.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Microneedle Patch Transdermal Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microneedle Patch Transdermal Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microneedle Patch Transdermal Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedle Patch Transdermal Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Microneedle Patch Transdermal Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Competitive Situation and Trends
2.8.1 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Microneedle Patch Transdermal Drug Delivery Systems Players 麻豆原创 Share by Revenue
2.8.3 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Scenario by Region
3.1 Global Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Facts & Figures by Country
3.4.1 North America Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microneedle Patch Transdermal Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Microneedle Patch Transdermal Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Facts & Figures by Country
3.5.1 Europe Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microneedle Patch Transdermal Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Microneedle Patch Transdermal Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microneedle Patch Transdermal Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Microneedle Patch Transdermal Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microneedle Patch Transdermal Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Microneedle Patch Transdermal Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microneedle Patch Transdermal Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microneedle Patch Transdermal Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Microneedle Patch Transdermal Drug Delivery Systems Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Microneedle Patch Transdermal Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Microneedle Patch Transdermal Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Microneedle Patch Transdermal Drug Delivery Systems Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Microneedle Patch Transdermal Drug Delivery Systems Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Microneedle Patch Transdermal Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 3M Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Becton
6.2.1 Becton Company Information
6.2.2 Becton Description and Business Overview
6.2.3 Becton Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Becton Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.2.5 Becton Recent Developments/Updates
6.3 Endoderma
6.3.1 Endoderma Company Information
6.3.2 Endoderma Description and Business Overview
6.3.3 Endoderma Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Endoderma Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.3.5 Endoderma Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Zosano Pharma
6.5.1 Zosano Pharma Company Information
6.5.2 Zosano Pharma Description and Business Overview
6.5.3 Zosano Pharma Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zosano Pharma Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.5.5 Zosano Pharma Recent Developments/Updates
6.6 Raphas
6.6.1 Raphas Company Information
6.6.2 Raphas Description and Business Overview
6.6.3 Raphas Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Raphas Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.6.5 Raphas Recent Developments/Updates
6.7 Nanopass Tech
6.7.1 Nanopass Tech Company Information
6.7.2 Nanopass Tech Description and Business Overview
6.7.3 Nanopass Tech Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nanopass Tech Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.7.5 Nanopass Tech Recent Developments/Updates
6.8 Corium International
6.8.1 Corium International Company Information
6.8.2 Corium International Description and Business Overview
6.8.3 Corium International Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Corium International Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.8.5 Corium International Recent Developments/Updates
6.9 Valeritas
6.9.1 Valeritas Company Information
6.9.2 Valeritas Description and Business Overview
6.9.3 Valeritas Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Valeritas Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.9.5 Valeritas Recent Developments/Updates
6.10 Nitto Denko
6.10.1 Nitto Denko Company Information
6.10.2 Nitto Denko Description and Business Overview
6.10.3 Nitto Denko Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nitto Denko Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.10.5 Nitto Denko Recent Developments/Updates
6.11 Microdermics
6.11.1 Microdermics Company Information
6.11.2 Microdermics Description and Business Overview
6.11.3 Microdermics Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Microdermics Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.11.5 Microdermics Recent Developments/Updates
6.12 TheraJect
6.12.1 TheraJect Company Information
6.12.2 TheraJect Description and Business Overview
6.12.3 TheraJect Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 TheraJect Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.12.5 TheraJect Recent Developments/Updates
6.13 Vaxxas
6.13.1 Vaxxas Company Information
6.13.2 Vaxxas Description and Business Overview
6.13.3 Vaxxas Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vaxxas Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.13.5 Vaxxas Recent Developments/Updates
6.14 KINDEVA
6.14.1 KINDEVA Company Information
6.14.2 KINDEVA Description and Business Overview
6.14.3 KINDEVA Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.14.4 KINDEVA Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.14.5 KINDEVA Recent Developments/Updates
6.15 QuadMedicine
6.15.1 QuadMedicine Company Information
6.15.2 QuadMedicine Description and Business Overview
6.15.3 QuadMedicine Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.15.4 QuadMedicine Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.15.5 QuadMedicine Recent Developments/Updates
6.16 SNvia
6.16.1 SNvia Company Information
6.16.2 SNvia Description and Business Overview
6.16.3 SNvia Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.16.4 SNvia Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.16.5 SNvia Recent Developments/Updates
6.17 Small Lab
6.17.1 Small Lab Company Information
6.17.2 Small Lab Description and Business Overview
6.17.3 Small Lab Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Small Lab Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.17.5 Small Lab Recent Developments/Updates
6.18 Lohmann Therapie-Systeme
6.18.1 Lohmann Therapie-Systeme Company Information
6.18.2 Lohmann Therapie-Systeme Description and Business Overview
6.18.3 Lohmann Therapie-Systeme Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Lohmann Therapie-Systeme Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.18.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.19 AdminMed Nano BioSciences
6.19.1 AdminMed Nano BioSciences Company Information
6.19.2 AdminMed Nano BioSciences Description and Business Overview
6.19.3 AdminMed Nano BioSciences Microneedle Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AdminMed Nano BioSciences Microneedle Patch Transdermal Drug Delivery Systems Product Portfolio
6.19.5 AdminMed Nano BioSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedle Patch Transdermal Drug Delivery Systems Industry Chain Analysis
7.2 Microneedle Patch Transdermal Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedle Patch Transdermal Drug Delivery Systems Production Mode & Process Analysis
7.4 Microneedle Patch Transdermal Drug Delivery Systems Sales and 麻豆原创ing
7.4.1 Microneedle Patch Transdermal Drug Delivery Systems Sales Channels
7.4.2 Microneedle Patch Transdermal Drug Delivery Systems Distributors
7.5 Microneedle Patch Transdermal Drug Delivery Systems Customer Analysis
8 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Dynamics
8.1 Microneedle Patch Transdermal Drug Delivery Systems Industry Trends
8.2 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Drivers
8.3 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Challenges
8.4 Microneedle Patch Transdermal Drug Delivery Systems 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
3M
Becton
Endoderma
BD
Zosano Pharma
Raphas
Nanopass Tech
Corium International
Valeritas
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
SNvia
Small Lab
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
听
听
*If Applicable.
